Ticagrelor 60 mg Tablet | PCD Pharma Manufacturer & Supplier India | Trumac Healthcare
Ticagrelor 60 mg Tablet
WHO-GMP Manufacturer & PCD Pharma Franchise Supplier in India
Form: Tablet
Class: Reversible direct-acting P2Y12 receptor antagonist
✓ Pan-India Monopoly PCD
✓ 1 Brand Options
Pricing, brochure & monopoly territory within 24 hrs.
Our Ticagrelor 60 mg Tablet Brand Options (1 option)
Trumac Healthcare manufactures and supplies the following Ticagrelor 60 mg Tablet brands for PCD pharma distribution. Click any brand to view full specifications and packaging.
Ticagrelor 60 mg Tablet is manufactured under WHO-GMP-certified conditions by Trumac Healthcare and supplied for PCD/Propaganda-cum-Distribution pharma franchise on monopoly basis across India. Whether you are a PCD distributor, stockist or retail chemist, our Ticagrelor 60 mg formulation comes with full quality assurance, regulatory documentation and reliable pan-India despatch.
Therapeutic Indications
- Acute coronary syndrome (STEMI/NSTEMI) with PCI or medical management
- Long-term post-MI atherothrombotic event prevention
- Adjunct to aspirin in dual antiplatelet therapy
Mechanism of Action
Ticagrelor reversibly binds the P2Y12 ADP receptor on platelets at a different site than thienopyridines, blocking ADP-mediated platelet activation. Faster onset, stronger and more consistent inhibition, with reversibility allowing faster recovery before surgery.
Dosage & Administration
- Loading dose: 180 mg (two 90 mg tablets) once at start of treatment
- Maintenance: 90 mg twice daily for 12 months post-ACS
- Long-term post-MI: 60 mg twice daily
- Take with aspirin 75–100 mg daily
Side Effects
- Bleeding (major and minor)
- Dyspnoea (10–15%, usually mild, transient)
- Bradycardia
- Increased creatinine and uric acid
- Hypersensitivity
Contraindications
- Active pathological bleeding
- Recent intracranial bleeding
- Severe hepatic impairment
- Concurrent strong CYP3A4 inhibitors/inducers
Storage
Store below 25°C.
PCD Pharma Franchise for Ticagrelor 60 mg Tablet
- ✓ WHO-GMP certified manufacturing facility
- ✓ Pan-India monopoly distribution rights available
- ✓ Multiple pack sizes: 10 x 14 (Blister)
- ✓ Trade-friendly PTR / PTS margins
- ✓ Free promotional material on request
- ✓ Full DCGI documentation and quality certificates supplied
Trumac Healthcare offers 1 brand option for Ticagrelor 60 mg Tablet — each available in different pack sizes with trade-friendly margins. View the brand-specific pages below for detailed specifications, MRPs and packaging options.
For PCD franchise opportunities, monopoly distribution rights, or third-party contract manufacturing of Ticagrelor 60 mg Tablet, contact our business development team. WhatsApp +91 9041677932 or email info@trumachealthcare.net.
Frequently Asked Questions
Who is the manufacturer of Ticagrelor 60 mg Tablet?
Trumac Healthcare is a WHO-GMP certified manufacturer of Ticagrelor 60 mg Tablet in India. We supply our own brand range (see brand options above) and also offer third-party contract manufacturing for PCD distributors.
Is Ticagrelor 60 mg Tablet available for PCD pharma franchise on monopoly basis?
Yes. We offer Ticagrelor 60 mg Tablet for PCD/Propaganda-cum-Distribution pharma franchise on monopoly basis across all districts of India. Contact our business development team for pricing and territory availability.
What pack sizes are available for Ticagrelor 60 mg Tablet?
Available pack sizes include: 10 x 14 (Blister).
What is the MRP / trade price for Ticagrelor 60 mg Tablet?
MRPs range from ₹2800 to ₹2800 across our brand variants. Trade-friendly PTR/PTS margins available on request — WhatsApp +91 9041677932 for current rates.
How do I place an order or franchise enquiry?
WhatsApp +91 9041677932 or email info@trumachealthcare.net with your enquiry. Our team will revert within 24 hours with full pricing, brochure and franchise terms.
Ready to start your PCD franchise for Ticagrelor 60 mg Tablet?